These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21725161)

  • 81. The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder.
    Qayyum T; Fyffe G; Duncan M; McArdle PA; Hilmy M; Orange C; Halbert G; Seywright M; Horgan PG; Underwood MA; Edwards J
    Br J Cancer; 2012 Mar; 106(6):1187-95. PubMed ID: 22353809
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Potential prognostic value of leptin receptor in hepatocellular carcinoma.
    Wang SN; Chuang SC; Yeh YT; Yang SF; Chai CY; Chen WT; Kuo KK; Chen JS; Lee KT
    J Clin Pathol; 2006 Dec; 59(12):1267-71. PubMed ID: 16565226
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma.
    Liu CH; Chen TC; Chau GY; Jan YH; Chen CH; Hsu CN; Lin KT; Juang YL; Lu PJ; Cheng HC; Chen MH; Chang CF; Ting YS; Kao CY; Hsiao M; Huang CY
    Mol Cell Proteomics; 2013 May; 12(5):1335-49. PubMed ID: 23397142
    [TBL] [Abstract][Full Text] [Related]  

  • 84. FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Alexandrou P; Patsouris E; Sastre-Garau X
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1369-77. PubMed ID: 22488171
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Amplification of MPZL1/PZR gene in hepatocellular carcinoma.
    Yeh YT; Dai HY; Chien CY
    Hepatobiliary Surg Nutr; 2014 Apr; 3(2):87-90. PubMed ID: 24812600
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Overexpression of CDT1 Is a Predictor of Poor Survival in Patients with Hepatocellular Carcinoma.
    Karavias D; Maroulis I; Papadaki H; Gogos C; Kakkos S; Karavias D; Bravou V
    J Gastrointest Surg; 2016 Mar; 20(3):568-79. PubMed ID: 26408331
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Phosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer.
    Cristóbal I; Manso R; Rincón R; Caramés C; Zazo S; Del Pulgar TG; Cebrián A; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Br J Cancer; 2014 Aug; 111(4):756-62. PubMed ID: 25003662
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Immunohistochemical and molecular analysis of tyrosine kinase activity in desmoid tumors.
    Cho NL; Carothers AM; Rizvi H; Hasson RM; Redston M; Bertagnolli MM
    J Surg Res; 2012 Apr; 173(2):320-6. PubMed ID: 21195420
    [TBL] [Abstract][Full Text] [Related]  

  • 89. c-Src kinase impairs the expression of mitochondrial OXPHOS complexes in liver cancer.
    Hunter CA; Koc H; Koc EC
    Cell Signal; 2020 Aug; 72():109651. PubMed ID: 32335258
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A discussion of serum albumin level in advanced-stage hepatocellular carcinoma: a medical oncologist's perspective.
    Tanriverdi O
    Med Oncol; 2014 Nov; 31(11):282. PubMed ID: 25316265
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cryptocaryone induces apoptosis in human hepatocellular carcinoma cells by inhibiting aerobic glycolysis through Akt and c-Src signaling pathways.
    Yu CL; Lai YW; Chen JJ; Lee JJ; Chou TH; Huang CC; Liu SC; Chen GW; Tsai CH; Wang SW
    J Food Drug Anal; 2023 Dec; 31(4):696-710. PubMed ID: 38526828
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Phosphatase regenerating liver 3 participates in Integrinβ1/FAK-Src/MAPK signaling pathway and contributes to the regulation of malignant behaviors in hepatocellular carcinoma cells.
    Chen G; Zhang Z; Li J; Hu C; Gao D; Chen J; Zhang L; Xie X
    J Gastrointest Oncol; 2023 Apr; 14(2):863-873. PubMed ID: 37201051
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Kahweol Induces Apoptosis in Hepatocellular Carcinoma Cells by Inhibiting the Src/mTOR/STAT3 Signaling Pathway.
    Seo HY; Lee SH; Lee JH; Lee JH; Jang BK; Kim MK
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638852
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.
    Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J
    Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned so Far.
    Martellucci S; Clementi L; Sabetta S; Mattei V; Botta L; Angelucci A
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32498343
    [TBL] [Abstract][Full Text] [Related]  

  • 96. SUMOylation and phosphorylation cross-talk in hepatocellular carcinoma.
    Tomasi ML; Ramani K
    Transl Gastroenterol Hepatol; 2018; 3():20. PubMed ID: 29780898
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer.
    Rühlmann F; Nietert M; Sprenger T; Wolff HA; Homayounfar K; Middel P; Bohnenberger H; Beissbarth T; Ghadimi BM; Liersch T; Conradi LC
    J Cancer; 2017; 8(7):1229-1237. PubMed ID: 28607598
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples.
    Peterson TA; Gauran IIM; Park J; Park D; Kann MG
    PLoS Comput Biol; 2017 Apr; 13(4):e1005428. PubMed ID: 28426665
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Elevated Src expression associated with hepatocellular carcinoma metastasis in northern Chinese patients.
    Zhao R; Wu Y; Wang T; Zhang Y; Kong D; Zhang L; Li X; Wang G; Jin Y; Jin X; Zhang F
    Oncol Lett; 2015 Nov; 10(5):3026-3034. PubMed ID: 26722284
    [TBL] [Abstract][Full Text] [Related]  

  • 100. CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells.
    Wang SJ; Cui HY; Liu YM; Zhao P; Zhang Y; Fu ZG; Chen ZN; Jiang JL
    Oncotarget; 2015 Jan; 6(1):243-57. PubMed ID: 25428919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.